Welcome to our dedicated page for Cibus news (Ticker: $CBUS), a resource for investors and traders seeking the latest updates and insights on Cibus stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cibus's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cibus's position in the market.
Rhea-AI Summary
The Environment Committee of the European Parliament has voted in favor of a new regulation on plants obtained by certain new genomic techniques (NGTs) and their food and feed, with the legislation moving to a plenary session of the European Parliament. Cibus, Inc. (Nasdaq: CBUS) welcomes the vote and the proposed regulation, which identifies a 'Conventional-like' category of NGT products that would be regulated as conventional varieties, bringing EU policy closer to that of trading partners in other countries. The legislation aims to ensure resilient and sustainable use of the EU's natural resources and has received support from Nobel Laureates and scientists for fostering innovation, enhancing food security, and boosting climate resilience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
-
Rhea-AI Summary
Cibus, Inc. (NASDAQ: CBUS) has announced successful field trials for its rice herbicide tolerance traits, HT1 and HT3, and its canola Pod Shatter Reduction (PSR) trait. The company is preparing for the commercial launch of these traits, with field scale demonstrations in the US Mid-South and plans to integrate the traits into product lines. Cibus also reported that its PSR trait in canola seed developer genetics performed well, leading to the first hybrid sales as early as 2025. The company aims to change the canola/WOSR market by broadly licensing its PSR trait to seed developers globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.22%
Tags
-
Rhea-AI Summary
Cibus, Inc. (NASDAQ: CBUS) successfully regenerates plants from single cells in a wheat cultivar, representing a major breakthrough for the company and the seed industry. This achievement accelerates trait development in wheat, a key crop for global food security, and demonstrates Cibus' success in developing scalable high throughput breeding platforms for major crops.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.27%
Tags
Rhea-AI Summary
Cibus, Inc. (Nasdaq: CBUS) collaborates with Interoc to introduce two herbicide tolerance traits for rice growers in Latin America, aiming to address weed management challenges and improve yields in the region.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.46%
Tags
-
Rhea-AI Summary
Cibus, Inc. (NASDAQ: CBUS) acknowledges the European Union notification to World Trade Organization (WTO) members on the European Commission proposal for regulation of plants obtained from New Genomic Techniques (NGTs). The proposal aims to regulate NGT products similar to conventional varieties, aligning EU policy with trading partners in North and South America, Australia, India, and Japan. The proposal was adopted by the EU College of Commissioners and is currently under review in committees of the European Parliament and by Ministers of Member States in the Council of the European Union. Members of the European Parliament are expected to vote on the proposal in January 2024, with an adoption date proposed in July 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
-
Rhea-AI Summary
Cibus, Inc. (Nasdaq: CBUS) has priced an underwritten offering of 2,106,723 shares of its Class A Common Stock and Pre-Funded Warrants to purchase up to 50,000 shares of its Class A Common Stock. The offering price is $9.00 per share, with gross proceeds estimated to be approximately $20.3 million. The offering is expected to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.33%
Tags
Rhea-AI Summary
Cibus, Inc. (NASDAQ: CBUS) acknowledges the European Union's proposal for the regulation of plants obtained from New Genomic Techniques (NGTs). The proposal aims to bring EU policy closer to that of trading partners in North and South America, Australia, India, and Japan. The proposal is a result of a European Commission study, requested by EU Member States, which concluded that EU GMO legislation was not fit for purpose in relation to applications of NGTs in plants. The proposal, currently under review, describes a category of NGTs producing modifications that could be obtained in nature or by conventional breeding, which would be regulated in the same way as conventional varieties. The proposal is scheduled for adoption in July 2024, with additional implementing acts required to be passed within 24 months for the new legislation to become fully operational.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.34%
Tags
-
Rhea-AI Summary
Cibus, Inc. (NASDAQ: CBUS) has announced the publication of a paper in the International Journal of Plant Biology, showcasing case studies of improving oleic oil content and developing pod shatter reduction in Brassica napus using gene editing tools on an industrial scale. The company's Trait Machine™ System has led to breakthroughs in breeding and scale, reducing timelines to develop new traits from as much as 16 years to approximately three to five years. Cibus is driving the speed and number of edited seed transfers of its pod shatter reduction trait to major seed company customers, with increased throughput allowing delivery of multiple elite genetic lines integrating into advanced commercial breeding programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.19%
Tags
-
Rhea-AI Summary
Cibus, Inc. (Nasdaq: CBUS) announced its financial results for the quarter ended September 30, 2023, and provided a business update. The company completed extensive field trials for its PSR trait in canola and HT1 and HT3 in rice. It also reported continued progress of its high-throughput soybean editing system and two advanced traits for Sclerotinia resistance and HT2. Cibus launched strategic realignment and cost savings initiatives to focus on advancing late-stage activities. Initial UK field trials for its PSR trait in WOSR are underway, and the company is accelerating its PSR trait in the European market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.76%
Tags
Rhea-AI Summary
Cibus, Inc. supports the European Commission's proposal to regulate plants obtained from new genomic techniques (NGTs) and their food and feed. The proposed regulation introduces a 'Conventional-like' category for NGT products, aligning EU policy with trading partners in North and South America, Australia, and Japan. The report highlights the potential of NGTs to enhance agriculture and food production in Europe. Cibus' gene editing platform products, such as disease-resistant canola and oilseed rape with reduced seed losses, would fall under the 'Conventional-like' category.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.79%
Tags
Cibus, Inc.
Nasdaq:CBUS
CBUS Rankings
CBUS Stock Data
368.84M
16.54M
17.74%
26.94%
1.8%
All Other Grain Farming
Agriculture, Forestry, Fishing and Hunting
United States of America
SAN DIEGO